Chapter 05 Risk Factors

Infection

Infectious agents are an important cause of cancer worldwide, especially in low- and middle-income countries.

While infections (bacteria, viruses, parasites) are responsible for an estimated 12% of new cancer cases annually worldwide, they cause more than one-quarter of all cancers in many low-income countries in Africa and Asia (Map 5.1).

The five most important cancer-causing infectious agents are Helicobacter pylori (850,000 cases globally), human papillomavirus (HPV) (730,000), hepatitis B virus (HBV) (380,000), hepatitis C virus (HCV) (170,000), and Epstein-Barr virus (EBV) (200,000) (Figure 5.1).

Human papillomavirus, Helicobacter pylori, and Hepatitis B and C viruses cause more than 90% of all infection-related cancers worldwide.

Figure 5.1

Leading cancer-causing infections worldwide (%), by sex, 2020

Heliobacter pylori
Hepatitis B virus
Hepatitis C virus
Epstein-Barr virus
Human Papillomavirus
Other Agents

MALES

FEMALES

The contribution of each infectious agent to cancer burden varies substantially across different regions (Figure 5.2).

Figure 5.2

Proportion (%) of cancers attributable to infectious agents, by agent and UN region, 2020

Helicobacter pylori
Hepatitis B virus
Hepatitis C virus
Epstein-Barr virus
Human Papillomavirus
Other Agents

Footnote

Sub-Saharan Africa includes sub-regions of Western, Middle, Eastern and South Africa.

Helicobacter pylori causes 90% of stomach cancers, the majority of which occur in Eastern Asia. HPV infection is a necessary cause of cervical cancer, the leading cause of cancer death among women in many low-income countries, and is also responsible for a substantial proportion of anal, vulvar, vaginal, penile, and head and neck cancers (Figure 5.3).

The major infection-related cancers are stomach, cervix, and liver.

Figure 5.3

Most common infection-related cancers worldwide, 2020

Worldwide, HBV and HCV infections account for 55% and 21% of liver cancer deaths, respectively, with HBV tending to be the predominant cause of liver cancer in less developed countries and HCV in more developed settings. EBV causes lymphomas, nasopharyngeal carcinoma, and 7% of stomach cancer. Other cancer-causing infections include Kaposi sarcoma-associated herpesvirus (HHV-8; 42,000 cases, mainly in sub-Saharan Africa), human T-cell lymphotropic virus, Merkel cell virus, liver flukes, and Schistosoma haematobium. Human immunodeficiency virus (HIV) also indirectly causes infection-related cancers through immunosuppression and is estimated, for example, to be responsible for 20% of cervical cancer and 80% of Kaposi sarcoma in sub-Saharan Africa.

“I stand by the HPV vaccine as a critical advancement in preventive healthcare. Its widespread adoption is essential to protect future generations from the devastating effects of HPV-related cancers.”

—Dr. Anthony Fauci Former Director of the National Institutes of Health (NIH)

Effective prevention strategies exist for infection-related cancers, including HPV and HBV vaccines, screening for cervical and anal HPV-related precancer, and drugs to treat HBV, HCV, Helicobacter pylori, and HIV infections. EBV vaccines and EBV-targeted immunotherapies are in development.

The World Health Organization (WHO) has launched global mobilization efforts for the elimination of liver cancer (HBV and HCV), and cervical cancer (HPV), as public health concerns.

Sources

Quotes


Maps

  • Map 5.1: de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. Feb 2020;8(2):e180-e190. doi:10.1016/s2214-109x(19)30488-7

Figures

  • Figures 5.1-5.3: de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. Feb 2020;8(2):e180-e190. doi:10.1016/s2214-109x(19)30488-7